vs
Side-by-side financial comparison of Evolv Technologies Holdings, Inc. (EVLV) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $38.5M, roughly 1.2× Evolv Technologies Holdings, Inc.). Evolv Technologies Holdings, Inc. runs the higher net margin — 28.3% vs -33.9%, a 62.2% gap on every dollar of revenue. On growth, Evolv Technologies Holdings, Inc. posted the faster year-over-year revenue change (32.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 31.8%).
Sentient Technologies was an American artificial intelligence technology company based in San Francisco. Sentient was founded in 2007 and received over $143 million in funding at different points after its inception. As of 2016, Sentient was the world's most well-funded AI company. It focused on e-commerce, online content and trading.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
EVLV vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.5M | $47.1M |
| Net Profit | $10.9M | $-16.0M |
| Gross Margin | 48.4% | 48.9% |
| Operating Margin | -20.7% | -17.7% |
| Net Margin | 28.3% | -33.9% |
| Revenue YoY | 32.3% | -15.6% |
| Net Profit YoY | 169.2% | 68.8% |
| EPS (diluted) | $0.07 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.5M | $47.1M | ||
| Q3 25 | $42.9M | $38.2M | ||
| Q2 25 | $32.5M | $38.4M | ||
| Q1 25 | $32.0M | $32.5M | ||
| Q4 24 | $29.1M | $55.8M | ||
| Q3 24 | $27.4M | $29.3M | ||
| Q2 24 | $25.2M | $34.0M | ||
| Q1 24 | $22.2M | $25.5M |
| Q4 25 | $10.9M | $-16.0M | ||
| Q3 25 | $-1.8M | $-23.8M | ||
| Q2 25 | $-40.5M | $202.5M | ||
| Q1 25 | $-1.7M | $-25.0M | ||
| Q4 24 | $-15.7M | $-51.1M | ||
| Q3 24 | $-30.4M | $-148.3M | ||
| Q2 24 | $3.4M | $-582.3M | ||
| Q1 24 | $-11.3M | $-72.3M |
| Q4 25 | 48.4% | 48.9% | ||
| Q3 25 | 49.7% | 35.5% | ||
| Q2 25 | 49.8% | 33.4% | ||
| Q1 25 | 59.8% | 32.4% | ||
| Q4 24 | 57.5% | -4.4% | ||
| Q3 24 | 57.8% | 21.2% | ||
| Q2 24 | 58.5% | 27.6% | ||
| Q1 24 | 54.8% | -95.0% |
| Q4 25 | -20.7% | -17.7% | ||
| Q3 25 | -20.1% | -33.6% | ||
| Q2 25 | -53.8% | -34.8% | ||
| Q1 25 | -45.0% | -65.0% | ||
| Q4 24 | -64.9% | -84.4% | ||
| Q3 24 | -70.0% | -493.2% | ||
| Q2 24 | -88.7% | -1705.5% | ||
| Q1 24 | -98.8% | -267.0% |
| Q4 25 | 28.3% | -33.9% | ||
| Q3 25 | -4.2% | -62.2% | ||
| Q2 25 | -124.6% | 527.8% | ||
| Q1 25 | -5.3% | -76.9% | ||
| Q4 24 | -54.0% | -91.6% | ||
| Q3 24 | -111.3% | -506.3% | ||
| Q2 24 | 13.6% | -1712.6% | ||
| Q1 24 | -50.8% | -283.9% |
| Q4 25 | $0.07 | $-4.40 | ||
| Q3 25 | $-0.01 | $-2.84 | ||
| Q2 25 | $-0.25 | $-1.79 | ||
| Q1 25 | $-0.01 | $-0.15 | ||
| Q4 24 | $-0.10 | $-15.29 | ||
| Q3 24 | $-0.19 | $-18.24 | ||
| Q2 24 | $0.02 | $-71.81 | ||
| Q1 24 | $-0.07 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.1M | $48.9M |
| Total DebtLower is stronger | $28.6M | — |
| Stockholders' EquityBook value | $119.4M | $-249.4M |
| Total Assets | $304.4M | $308.9M |
| Debt / EquityLower = less leverage | 0.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.1M | $48.9M | ||
| Q3 25 | $56.2M | $43.1M | ||
| Q2 25 | $36.9M | $40.8M | ||
| Q1 25 | $35.0M | $58.6M | ||
| Q4 24 | $51.9M | $56.3M | ||
| Q3 24 | $56.0M | $75.4M | ||
| Q2 24 | $56.5M | $89.6M | ||
| Q1 24 | $81.0M | $112.8M |
| Q4 25 | $28.6M | — | ||
| Q3 25 | $28.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $119.4M | $-249.4M | ||
| Q3 25 | $102.2M | $-235.7M | ||
| Q2 25 | $92.7M | $-214.1M | ||
| Q1 25 | $121.1M | $-417.5M | ||
| Q4 24 | $117.7M | $-398.4M | ||
| Q3 24 | $129.0M | $-344.1M | ||
| Q2 24 | $151.2M | $-203.2M | ||
| Q1 24 | $139.8M | $371.6M |
| Q4 25 | $304.4M | $308.9M | ||
| Q3 25 | $304.3M | $362.6M | ||
| Q2 25 | $280.4M | $379.2M | ||
| Q1 25 | $256.0M | $405.1M | ||
| Q4 24 | $268.1M | $437.4M | ||
| Q3 24 | $278.5M | $537.8M | ||
| Q2 24 | $269.1M | $691.5M | ||
| Q1 24 | $280.0M | $1.3B |
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | $8.2M | ||
| Q3 25 | $3.5M | $11.4M | ||
| Q2 25 | $2.1M | $-21.3M | ||
| Q1 25 | $-2.5M | $8.5M | ||
| Q4 24 | $3.2M | $-14.7M | ||
| Q3 24 | $3.7M | $-9.4M | ||
| Q2 24 | $-21.6M | $-11.9M | ||
| Q1 24 | $-16.2M | $-621.0K |
| Q4 25 | 1.43× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
